Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: A simulation study

Journal of Allergy and Clinical Immunology

Volumn 134, Issue 4, 2014, Pages 908-915.e3

  Zafari, Zafar ^a,c   Lynd, Larry D ^a,d   Fitzgerald, J Mark ^b,c   Sadatsafavi, Mohsen ^b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c VANCOUVER COASTAL HEALTH   (Canada)

^d CENTRE FOR HEALTH EVALUATION AND OUTCOME SCIENCES   (Canada)

Author keywords

adherence; Asthma; cost effectiveness analysis; decision analysis; evidence based treatment

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; COST EFFECTIVENESS ANALYSIS; DISEASE EXACERBATION; EVIDENCE BASED CONTROLLER THERAPY; HEALTH CARE COST; HEALTH STATUS; HIDDEN MARKOV MODEL; HUMAN; PATIENT CARE; PATIENT COMPLIANCE; PREVALENCE; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; SIMULATION; THERAPY; UNCONTROLLED ASTHMA; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; EVIDENCE BASED MEDICINE; MEDICATION COMPLIANCE; TIME; UNITED STATES;

ANTIASTHMATIC AGENT;

ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; COMPUTER SIMULATION; COST OF ILLNESS; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; HEALTH CARE COSTS; HUMANS; MARKOV CHAINS; MEDICATION ADHERENCE; QUALITY-ADJUSTED LIFE YEARS; TIME FACTORS; UNITED STATES;

EID: 84908124479     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.04.009     Document Type: Article

References (46)

1. K.B. Weiss, and S.D. Sullivan Socio-economic burden of asthma, allergy, and other atopic illnesses Pediatr Allergy Immunol 5 6 suppl 1994 7 12
2. H.A.H. Wijnhoven, D.M.W. Kriegsman, A.E. Hesselink, M. de Haan, and W. Stalman Disease control in general practice patients with asthma Prim Care Respir J 13 2004 89 98
3. J. Bousquet, P.J. Bousquet, P. Godard, and J.-P. Daures The public health implications of asthma Bull World Health Organ 83 2005 548 554
4. E.D. Bateman, H.A. Boushey, J. Bousquet, W.W. Busse, T.J.H. Clark, and R.A. Pauwels Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study Am J Respir Crit Care Med 170 2004 836 844
5. Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma Am J Respir Crit Care Med 175 2007 235 242
6. J.M. FitzGerald, L.-P. Boulet, R.A. McIvor, S. Zimmerman, and K.R. Chapman Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study Can Respir J 13 2006 253 259
7. The Global Initiative for Asthma (GINA). Available at: http://www.ginasthma.org/. Accessed February 7, 2014.
8. R Development Core Team. R: a language and environment for statistical computing. Available at: http://www.r-project.org/. Accessed February 7, 2014.
9. B.G. Carlton, D.O. Lucas, E.F. Ellis, K. Conboy-Ellis, O. Shoheiber, and D.A. Stempel The status of asthma control and asthma prescribing practices in the United States: results of a large prospective asthma control survey of primary care practices J Asthma 42 2005 529 535
10. L.K. Williams, M. Pladevall, H. Xi, E.L. Peterson, C. Joseph, and J.E. Lafata Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma J Allergy Clin Immunol 114 2004 1288 1293
11. A.H. Briggs, J. Bousquet, M.V. Wallace, W.W. Busse, T.J.H. Clark, and S.E. Pedersen Cost-effectiveness of asthma control: an economic appraisal of the GOAL study Allergy 61 2006 531 536
12. Arias E. United States life tables, 2007. Available from: http://www.cdc.gov. Accessed February 7, 2014.
13. Centers for Disease Control and Prevention, National Center for Health Statistics. CDC Wonder On-line Database, compiled from Compressed Mortality File 1999-2009 Series 20 No. 2O, 2012.
14. MIMS. MIMS: Prescription drug database and drug prescription guide. 2012, 59. Available at: http://mims.co.uk. Accessed February 7, 2014.
15. M. Sadatsafavi, R. Rousseau, W. Chen, W. Zhang, L. Lynd, and J.M. Fitzgerald The preventable burden of productivity loss due to suboptimal asthma control: a population-based study Chest 2013 [Epub ahead of print]
16. National Average Wage Index. The Official Website of the U.S. Social Security Administration. 2012. Available at: http://www.ssa.gov/oact/cola/AWI.html. Accessed February 7, 2014.
17. E.D. Bateman, J. Bousquet, W.W. Busse, T.J.H. Clark, N. Gul, and M. Gibbs Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study Allergy 63 2008 932 938
18. D.D. Sin, J. Man, H. Sharpe, W.Q. Gan, and S.F.P. Man Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis JAMA 292 2004 367 376
19. S.C. Lazarus, H.A. Boushey, J.V. Fahy, V.M. Chinchilli, R.F. Lemanske Jr., and C.A. Sorkness Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial JAMA 285 2001 2583 2593
20. R.A. Nathan, J.L. Pinnas, H.J. Schwartz, J. Grossman, S.W. Yancey, and A.H. Emmett A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma Ann Allergy Asthma Immunol 82 1999 521 529
21. R.A. Pauwels, S. Pedersen, W.W. Busse, W.C. Tan, Y.-Z. Chen, and S.V. Ohlsson Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial Lancet 361 2003 1071 1076
22. P.M. O'Byrne, P.J. Barnes, R. Rodriguez-Roisin, E. Runnerstrom, T. Sandstrom, and K. Svensson Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial Am J Respir Crit Care Med 164 2001 1392 1397
23. K. Malmstrom, G. Rodriguez-Gomez, J. Guerra, C. Villaran, A. Piñeiro, and L.X. Wei Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group Ann Intern Med 130 1999 487 495
24. M.C. Weinstein, J.E. Siegel, M.R. Gold, M.S. Kamlet, and L.B. Russell Recommendations of the Panel on Cost-effectiveness in Health and Medicine JAMA 276 1996 1253 1258
25. Cost-Effectiveness analysis of a pharmacy asthma care program: disease management and health outcomes. Available at: http://adisonline.com/diseasemanagement/Fulltext/2007/15060/Cost-Effectiveness-Analysis-of-a-Pharmacy-Asthma.6.aspx. Accessed February 27, 2013.
26. V. Van der Meer, W.B. van den Hout, M.J. Bakker, K.F. Rabe, P.J. Sterk, and W.J.J. Assendelft Cost-effectiveness of Internet-based self-management compared with usual care in asthma PLoS One 6 2011 e27108
27. M. Axelsson, and J. Lotvall Recent educational interventions for improvement of asthma medication adherence Asia Pac Allergy 2 2012 67 75
28. D. Ryan, D. Price, S.D. Musgrave, S. Malhotra, A.J. Lee, and D. Ayansina Clinical and cost effectiveness of mobile phone supported self monitoring of asthma: multicentre randomised controlled trial BMJ 344 2012 e1756
29. T.A. Lee, C.-L. Chang, J.J. Stephenson, S.G. Sajjan, E.M. Maiese, and S. Everett Impact of asthma controller medications on medical and economic resource utilization in adult asthma patients Curr Med Res Opin 26 2010 2851 2860
30. S. Mattke, F. Martorell, S.Y. Hong, P. Sharma, A. Cuellar, and N. Lurie Anti-inflammatory medication adherence and cost and utilization of asthma care in a commercially insured population J Asthma 47 2010 323 329
31. A. Schlender, P.E. Alperin, H.L. Grossman, and E.R. Sutherland Modeling the impact of increased adherence to asthma therapy PLoS One 7 2012 e51139
32. L.K. Williams, E.L. Peterson, K. Wells, B.K. Ahmedani, R. Kumar, and E.G. Burchard Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence J Allergy Clin Immunol 128 2011 1185 1191.e2
33. A. Boudier, I. Curjuric, X. Basagaña, H. Hazgui, J.M. Anto, and J. Bousquet 10 Year-follow up of cluster-based asthma phenotypes in adults. A pooled analysis of three cohorts Am J Respir Crit Care Med 188 2013 550 560
34. J.L. Brozek, M. Kraft, J.A. Krishnan, M.M. Cloutier, S.C. Lazarus, and J.T. Li Long-acting β2-agonist step-off in patients with controlled asthma Arch Intern Med 172 2012 1365 1375
35. B.F. Chauhan, C. Chartrand, and F.M. Ducharme Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults Cochrane Database Syst Rev 2013 CD009611
36. Long-term effects of budesonide or nedocromil in children with asthma N Engl J Med 343 2000 1054 1063
37. R.B. Haynes, E. Ackloo, N. Sahota, H.P. McDonald, and X. Yao Interventions for enhancing medication adherence Cochrane Database Syst Rev 2008 CD000011
38. Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock S, Wines RCM, et al. Closing the quality gap series: medication adherence interventions: comparative effectiveness. evidence reports/technology assessments, no. 2084. Available at: http://effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?productid=1248&pageaction=displayproduct. Accessed March 21, 2014.
39. B.G. Carlton, D.O. Lucas, E.F. Ellis, K. Conboy-Ellis, O. Shoheiber, and D.A. Stempel The status of asthma control and asthma prescribing practices in the United States: results of a large prospective asthma control survey of primary care practices J Asthma 42 2005 529 535
40. L.K. Williams, M. Pladevall, H. Xi, E.L. Peterson, C. Joseph, and J.E. Lafata Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma J Allergy Clin Immunol 114 2004 1288 1293
41. E.D. Bateman, J. Bousquet, W.W. Busse, T.J.H. Clark, N. Gul, and M. Gibbs Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study Allergy 63 2008 932 938
42. D.D. Sin, J. Man, H. Sharpe, W.Q. Gan, and S.F.P. Man Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis JAMA 292 2004 367 376
43. R.A. Pauwels, S. Pedersen, W.W. Busse, W.C. Tan, Y.-Z. Chen, and S.V. Ohlsson Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial Lancet 361 2003 1071 1076
44. P.M. O'Byrne, P.J. Barnes, R. Rodriguez-Roisin, E. Runnerstrom, T. Sandstrom, and K. Svensson Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial Am J Respir Crit Care Med 164 2001 1392 1397
45. K. Malmstrom, G. Rodriguez-Gomez, J. Guerra, C. Villaran, A. Piñeiro, and L.X. Wei Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group Ann Intern Med 130 1999 487 495
46. L.K. Williams, E.L. Peterson, K. Wells, B.K. Ahmedani, R. Kumar, and E.G. Burchard Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence J Allergy Clin Immunol 128 2011 1185 1191.e2